Subscribe To
Cti biopharma to report second quarter 2022 financial results on august 8, 2022
– Company Also Announces Participation in the BTIG Biotechnology Conference and the Stifel biotech Su...
August 1, 2022, 8:37 am
Where will crispr therapeutics be in 1 year?
The next 12 months could look very different from the past year for this biotech company....
July 31, 2022, 11:00 am
Evaxion biotech to host q2 2022 corporate update conference call & webcast on august 10
COPENHAGEN, Denmark, July 29, 2022 (GLOBE NEWSWIRE) -- Evaxion biotech A/S (NASDAQ: EVAX) (“Evaxion�...
July 29, 2022, 5:46 pm
Why moderna was a stock market star on friday
The biotech keeps up a steady supply of coronavirus vaccine boosters to a very reliable customer....
July 29, 2022, 4:41 pm
Celyad oncology to announce first half 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium, July 28, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...
July 28, 2022, 1:05 am
Celyad oncology to announce first half 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD)...
July 28, 2022, 1:00 am
Exclusive: eu antitrust regulators likely to block illumina, grail deal - sources
EU antitrust regulators are expected to veto U.S. life sciences firm Illumina's acquisition of biotechnology company Grail, people familiar with the m...
July 27, 2022, 9:16 am
Why novavax stock jumped on tuesday
The biotech company got good news about its COVID-19 vaccine....
July 26, 2022, 4:40 pm
Shares of verve therapeutics up 84% in past month; get exposure with arkg
The biotech sector can offer unique opportunities and strong returns to investors willing to stomach th...
July 26, 2022, 4:31 pm
Eiger biopharmaceuticals: undervalued biotech with end of 2022 catalyst
European Commission granted marketing authorization for Zokinvy (lonafarnib) for the treatment of patients with progeria on July 20, 2022. Results fro...
July 26, 2022, 7:52 am
22nd century group's road to cannabis may have some potholes
The biotechnology company is working hard to get up to speed, but it risks running out of highway....
July 26, 2022, 6:07 am
Fosun pharma shares gain after tie-up with new covid drug supplier genuine biotech
Genuine biotech rec'd China approval on Monday for use of HIV drug in Covid-19 treatment...
July 25, 2022, 10:44 pm
Ginkgo buys embattled biotech firm zymergen for paltry $300 million
The deal values Zymergen at a fraction of its $3 billion valuation at Zymergen's IPO last April....
July 25, 2022, 9:23 am
Clearpoint neuro: a 'picks and shovels' biotech company
CLPT has been growing revenues steadily and has a large addressable market. It also has a very strong moat due to the nature of the FDA approval proce...
July 25, 2022, 4:12 am
Stevanato group to report second quarter 2022 financial results on august 4, 2022
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost...
July 22, 2022, 4:03 pm
2 biotech stocks to help recession-proof your portfolio
These companies' shares have outpaced the market and other biotech stocks this year....
July 22, 2022, 10:45 am
Capitalize on biotech growth in china with this etf
After a rough 2021 that featured the Evergrande Crisis and heavy regulatory measures on technology to keep monopolistic moves in check, investors are ...
July 21, 2022, 12:11 pm
Is it time to buy the dip with biotech stocks?
Right now, it's even riskier to buy biotechs than normal....
July 21, 2022, 10:23 am
Daily biotech pulse: liver disease-focused gene therapy pact, assembly bio stops hbv infection trial, x4 pharma looks for partners
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Verve...
July 21, 2022, 10:21 am
Cyclo therapeutics to present at the nnpdf-inpda conferences 2022
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechn...
July 21, 2022, 8:05 am